Skip to main content
Premium Trial:

Request an Annual Quote

Singapore Clears New SARS-CoV-2 Assay for Clinical Use

NEW YORK – A new test for SARS-CoV-2 has received provisional authorization for clinical use from Singapore's Health Sciences Authority, according to the Agency for Science, Technology, and Research (A*STAR).

A*STAR and Tan Tock Seng Hospital of Singapore developed the test, which is the first diagnostic to be deployed in the country's hospitals since the outbreak began in December.

The test, called A*STAR Fortitude 2.0, is a real-time PCR assay. Results are generated using a nasopharyngeal swab collected from patients. The product supports the analysis of up to 188 samples per kit.

MiRxes, a Singapore-based diagnostics company that has developed a quantitative PCR-based test for gastric cancer, said that it has been manufacturing the new A*STAR Fortitude 2.0 Kit.

The company reported that it has manufactured 100,000 tests in the past few weeks and has shipped around 20,000 tests to local and regional hospitals. An A*STAR spokesperson confirmed in an email that MiRxes has a nonexclusive license to manufacture the kit, and that A*STAR and its partners are looking to license the test to other manufacturers in Singapore.

There have been 110 cases confirmed in Singapore since Jan. 23, according to the Singapore Ministry of Health. Thirty-two remain hospitalized. No one so far has died of the disease.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.